S. 2121 · 119th Congress (2025–2027)
SUPPORT for Patients and Communities Reauthorization Act of 2025
This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.
For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to
• addressing substance use disorders with respect to pregnant and postpartum women,
• prevention and recovery from substance use disorders for youth,
• housing for individuals in recovery from substance use disorders,
• community organizations facilitating recovery from substance use disorders,
• loan repayment for certain health care providers treating substance use disorders,
• prevention of overdoses of controlled substances,
• treatment of children experiencing psychological trauma, and
• mental and behavioral health education and training for medical and allied health students.
Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.
Additionally, the bill establishes new requirements for HHS, including requirements relating to
• protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
• establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
• reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.
Show official title
A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 2121’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Bill Cassidy (R-LA)
- Cosponsors
8 cosponsors
7 original · 1 later
4 R · 3 D · 1 I
- Sen. Tammy Baldwin (D-WI)· Original · Jun 18, 2025
- Sen. John W. Hickenlooper (D-CO)· Original · Jun 18, 2025
- Sen. Margaret Wood Hassan (D-NH)· Original · Jun 18, 2025
- Sen. Lisa Murkowski (R-AK)· Original · Jun 18, 2025
- Sen. Markwayne Mullin (R-OK)· Original · Jun 18, 2025
- Sen. Bernard Sanders (I-VT)· Original · Jun 18, 2025
- Sen. Tommy Tuberville (R-AL)· Original · Jun 18, 2025
- Sen. Jon Husted (R-OH)· Later · Jul 16, 2025
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
SUPPORT for Patients and Communities Reauthorization Act of 2025
Display title, Short title · Introduced in Senate
A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
Official title · Introduced in Senate